Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05204719 · ClinicalTrials.gov registry record · NA
Prophylactic DR-CPAP on Late Preterm Infants Born by C-section: an RCT
A NA study of Premature Birth, sponsored by University of Oklahoma.
- Active
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 5
- Study locations
NCT05204719: Active NA study of Premature Birth, sponsored by University of Oklahoma.
NCT05204719 is a NA study of Premature Birth that is active but no longer recruiting, run by University of Oklahoma. The registered enrollment target is 120 participants, below the 391-participant average among 38 other Premature Birth trials with a reported enrollment target (69% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05204719, a NA study of Premature Birth, is active but no longer recruiting, sponsored by University of Oklahoma.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 5
- Study locations
Study Summary
A Pragmatic Randomized Controlled Pilot Trial to Evaluate the Impact of Early Prophylactic Continuous Positive Airway Pressure with or without Supplemental Oxygen in Spontaneously Breathing Late Preterm Newborn Infants Born by Cesarean Delivery, Compared to No Early Prophylactic Continuous Positive Airway Pressure with or without Supplemental Oxygen, on the Need for Further Respiratory Support Leading to NICU Admissions.
Primary Outcome
Duration of respiratory support including supplemental oxygen
Conditions Studied
Interventions
- PROCEDURE Prophylactic Delivery Room Continuous Positive Airway Pressure
Study Locations (5)
Indiana
- Indiana University - Indianapolis
Missouri
- Saint Louis University - St Louis
Oklahoma
- The University of Oklahoma Health Campus - Oklahoma City
Alberta
- University of Alberta - Edmonton
Santiago Metropolitan
- Pontificia Universidad Católica de Chile - Santiago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-08-04 |
| Est. Completion | 2025-12 |
| Phase | NA |
What the registry record for NCT05204719 still lists
NCT05204719 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 391-participant average among 38 other Premature Birth trials with a reported enrollment target (69% lower).
The record links to 1 condition, with Premature Birth appearing as the primary indexed condition, and to 1 intervention - of which Prophylactic Delivery Room Continuous Positive Airway Pressure is the first listed.
NCT05204719 lists 5 locations in 5 states (Indiana, Missouri, Oklahoma).
Frequently Asked Questions
What is clinical trial NCT05204719 about?
NCT05204719 is a clinical study titled "Prophylactic DR-CPAP on Late Preterm Infants Born by C-section: an RCT". A Pragmatic Randomized Controlled Pilot Trial to Evaluate the Impact of Early Prophylactic Continuous Positive Airway Pressure with or without Supplemental Oxygen in Spontaneously Breathing Late Preterm Newborn Infants Born by Cesarean Delivery, Compared to No Early Prophylactic Continuous Positive ...
What is the current status of trial NCT05204719?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2023-08-04. Estimated completion is 2025-12.
What conditions does trial NCT05204719 study?
This clinical trial studies the following conditions: Premature Birth.
What interventions are being tested in trial NCT05204719?
The interventions under investigation include: Prophylactic Delivery Room Continuous Positive Airway Pressure (PROCEDURE).
Who is sponsoring clinical trial NCT05204719?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05204719 being conducted?
This trial has 5 study locations across Indiana, Missouri, Oklahoma, Alberta, Santiago Metropolitan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Premature Birth
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05204719's enrollment target sits among peer trials
120 19th of 38 higher than 19 of 38 other Premature Birth trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Premature Birth trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Randomized Controlled Trial of Impact of Wearable, Wireless Breast Pumps on Frequency and Efficacy of Milk Expression in Mothers of Premature Infants
RECRUITING · NA
-
Optimizing Family Counseling for Anticipated Extremely Preterm Delivery
RECRUITING · NA
-
The Periviable GOALS Decision Support Tool
RECRUITING · NA
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants
RECRUITING · NA
-
Healing Tiny Minds: Rural Recovery Through Virtual and Lived Experience Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI